Buy Egrifta (tesamorelin) from Canada

Cold-Chain Shipping Notice

This medication requires specialized cold-chain packaging to help maintain its quality and integrity during transit. Each shipment includes a temperature indicator to monitor storage conditions throughout the shipping process.

Do NOT use this medication if the attached temperature indicator shows that it was exposed to temperatures below 2°C (36°F) or above 8°C (46°F). If the temperature indicator shows that the acceptable temperature range has been exceeded, or if you have any concerns about the condition of your shipment upon arrival, do not use the medication and contact our pharmacy immediately for further instructions and assistance.

Please inspect your shipment and the temperature indicator as soon as it is delivered.

What is Egrifta?

Egrifta (tesamorelin) is a prescription treatment used to reduce excess belly fat in adults living with HIV who have a condition called lipodystrophy.

Lipodystrophy is when body fat is not distributed normally, often leading to fat buildup deep in the abdomen, also called visceral fat. This type of fat surrounds internal organs and is harder to reduce with diet and exercise alone.

Egrifta is given as a daily injection under the skin and works by stimulating the body to release more growth hormone, which helps break down this deep abdominal fat.

Patients may buy Egrifta online or in Canada to manage treatment costs, as the Egrifta price and Egrifta cost can vary.

Indications and Benefits of Egrifta

Egrifta is indicated for adults with HIV who develop excess abdominal fat due to lipodystrophy. 

This condition can affect appearance and may also put pressure on internal organs. Egrifta helps target visceral fat, which is the deeper and more harmful type of fat in the abdomen.

It is important to note that Egrifta is not a general weight loss treatment.

What Are the Benefits of Egrifta?

• Helps reduce deep abdominal fat that is difficult to manage with diet and exercise alone.
• Targets visceral fat, which surrounds internal organs and is linked to higher health risks.
• Supports a more balanced body shape in people with HIV-related lipodystrophy.
• May help reduce pressure on internal organs caused by excess fat buildup.
• Works by increasing natural growth hormone levels, which helps break down stored fat.
• Uses a once-daily injection routine that is simple and consistent.
• Allows targeted treatment through proper injection into the abdominal area.
• Can be adjusted by a healthcare provider based on response and treatment goals.
• Provides an option when lifestyle changes alone are not enough to reduce visceral fat.
• Can be considered alongside Egrifta alternatives when evaluating treatment options.

Egrifta Fact Table

How It Works

Egrifta works by helping the body release more natural growth hormone, which plays a role in how fat is processed and broken down.

Growth hormone sends signals that tell the body to use stored fat for energy, especially the deep fat found in the abdomen. This type of fat, called visceral fat, sits around internal organs and is harder to reduce through diet and exercise alone.

By increasing growth hormone levels, Egrifta helps reduce this harmful fat over time.

The treatment focuses on fat metabolism, which means how the body stores and uses fat, rather than simply reducing overall body weight.

Dosage

Egrifta dosing depends on the specific formulation prescribed, either Egrifta WR or Egrifta SV. Both are given as a daily injection under the skin of the abdomen.

The exact dose, preparation, and amount used may differ between the two versions, so they are not interchangeable.

Your doctor will guide proper use, including how to prepare the solution and follow the correct injection technique.

What Dosage Strengths Does Egrifta Come In?

• Egrifta WR 11.6 mg per vial
• Egrifta SV 2 mg per vial

Egrifta Recommended Dosage Chart

Usage Guide

Egrifta is used as a daily injection under the skin of the abdomen to help reduce excess belly fat linked to HIV-associated lipodystrophy.

Proper use is important to get the best results and reduce the risk of side effects. A healthcare provider will guide how to prepare and inject the dose, whether using Egrifta WR or Egrifta SV. 

Since these two versions have different dosing and preparation steps, they should not be switched without medical guidance.

Following correct Egrifta injection instructions, using proper injection sites, and keeping a consistent daily schedule will help improve treatment outcomes.

How do you use Egrifta?

• Follow the prescribed dosing schedule carefully.
• Inject the dose under the skin of the abdomen using the correct technique.
• Prepare the injection properly before each use.
• Rotate injection areas on the abdomen each day to reduce irritation.
• Avoid injecting into scar tissue, bruises, or the belly button.
• Use the injection at the same time each day for consistency.
• Do not share syringes or needles to prevent serious infections.
• Dispose of used needles and supplies safely after each use.
• Seek guidance if there are questions or if any unusual reactions occur.

Side Effects

Egrifta side effects can vary from mild to serious depending on how the body responds to treatment.

This injectable therapy works by increasing growth hormone levels, which can affect different systems in the body. Most reactions are manageable, but some may require medical attention.

Common Side Effects

• Pain in the legs and arms, which may feel like soreness or discomfort
• Muscle pain that can occur during daily activities
• Injection site reactions such as redness, itching, or mild swelling
• Bruising or irritation around the injection area
• Mild swelling in the hands, feet, or joints

Serious Side Effects

• Increased risk of new cancer or return of previous cancer symptoms
• High levels of insulin-like growth factor 1 may require blood test monitoring
• Increase in blood sugar levels, which may lead to diabetes or worsen existing diabetes
• Fluid retention that may cause swelling, joint pain, or numbness in the hands and wrists
• Severe allergic reactions such as rash, hives, swelling of the face or throat, or difficulty breathing
• Severe injection site reactions, including pain, bleeding, or significant swelling
• Increased risk of serious complications in people with critical illness, especially after surgery or breathing problems

Missed Dose

If a dose of Egrifta is missed, skip the missed dose and take the next dose at the usual scheduled time.

Do not take two doses at the same time to make up for a missed one.

Keeping a consistent daily schedule is important for maintaining stable results, so try to take each dose at the same time every day.

Overdose

Using more than the prescribed amount of Egrifta may increase the risk of side effects such as swelling, joint pain, or changes in blood sugar levels. If too much is taken, seek medical help right away.

Close monitoring may be needed to manage symptoms and prevent complications.

Storage Information

Egrifta should be stored at room temperature between 20°C and 25°C and kept in its original packaging to protect it from light. Do not freeze.

After mixing, follow the recommended time for use and discard any unused solution as instructed.

Keep all supplies in a clean and dry place, and store them out of reach of children.

Warnings

Egrifta warnings and precautions are important to understand before starting treatment. This injectable therapy affects hormone levels and fat metabolism, which can impact different parts of the body.

Not everyone is suitable for this treatment, especially those with certain health conditions.

• Do not use Egrifta if there is a history of pituitary gland tumor, surgery, or injury because this part of the brain controls hormone release.
• Avoid use if there is active cancer or if previous cancer is not fully treated, since growth hormone activity may increase the risk.
• Do not use if there is an allergy to tesamorelin or any ingredient in the formulation.
• Do not use during pregnancy because it may harm the unborn baby.
• Use caution if there is a history of cancer, as there may be a risk of recurrence.
• Monitor blood sugar closely, especially in people with diabetes, because levels may increase during treatment.
• Watch for changes in vision or eye problems if blood sugar levels rise.
• Inform a medical professional before any planned surgery, including heart or stomach procedures.
• Use caution in people with breathing problems, as certain conditions may increase risk.
• Avoid breastfeeding, since it is not known if the drug passes into breast milk and there is a risk of HIV transmission.
• Always review other drugs, supplements, or vitamins being used to avoid potential interactions.

Boxed Warning and Precautions for Egrifta

Contraindications

Egrifta should not be used in certain conditions due to safety risks. This treatment is contraindicated, which means it should be avoided, in people with a history of pituitary gland problems.

The pituitary gland is a small part of the brain that controls hormone release, so any tumor, surgery, or injury in this area can affect how the treatment works.

Use is also not recommended for anyone with active cancer or cancer that has not been fully treated, because the increase in hormone activity may cause cancer to grow or return.

People who are allergic to tesamorelin or any of the ingredients should not use Egrifta, as this may lead to serious allergic reactions.

Egrifta is also not safe during pregnancy because it may harm the unborn baby.

Interactions

• CYP450 metabolized drugs such as simvastatin, atorvastatin, and lovastatin
• Corticosteroids such as hydrocortisone, dexamethasone, methylprednisolone
• Sex steroids such as estradiol, testosterone, and progesterone
• Anticonvulsants such as phenytoin, carbamazepine, and valproic acid
• Cyclosporine
• Glucocorticoids such as prednisone, prednisolone
• Cortisone acetate
• Prednisone

Alternatives

Egrifta alternatives may be considered based on individual needs, treatment goals, and underlying health conditions.

One option is Myalept (metreleptin), which works differently by replacing leptin, a hormone that helps regulate fat storage and metabolism. This option is mainly used in specific fat disorders and may be suitable in certain cases of abnormal fat distribution.

Other alternatives, such as growth hormone therapies or metabolic support treatments, may also be considered, depending on the condition being treated.

Choosing the right option depends on medical history, response to treatment, and overall health goals.

How to Order?

About Buy Canadian Insulin Services

Buy Canadian Insulin works with participating pharmacy partners to help patients access prescription medications and related healthcare products.

Product availability, pricing, and shipping timelines may vary depending on supplier inventory, participating pharmacy partner availability, and destination location.

Some prescription orders may be fulfilled through licensed pharmacy partners located in Canada or other international fulfillment locations depending on product availability.

Orders are packaged according to pharmacy handling and shipping procedures.

Have a prescription?

Order Egrifta online today and enjoy a host of benefits, including:

Frequently Asked Questions

Disclaimer

Buy Canadian Insulin provides educational information about medications and health conditions for informational purposes only. This content is not intended to replace professional medical advice, diagnosis, or treatment. Prescription medications require valid prescription review and processing through participating pharmacy partners. Product availability, pricing, and shipping timelines may vary. Consult your healthcare provider or pharmacist before starting, stopping, or changing any medication.